Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
YMAB
Stock Latest News
Company Announcements
Y-Mabs Therapeutics’ Phase 2 Trial: A Potential Breakthrough for Neuroblastoma Treatment
2d ago
YMAB
Premium
Company Announcements
Y-mAbs Therapeutics Reports Q2 Earnings and Acquisition
1M ago
YMAB
Premium
The Fly
Y-mAbs Therapeutics reports Q2 EPS (7c), consensus (25c)
1M ago
YMAB
Premium
The Fly
Y-mAbs Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
1M ago
YMAB
Premium
The Fly
Y-mAbs Therapeutics downgraded to Perform from Outperform at Oppenheimer
1M ago
YMAB
Premium
The Fly
Y-mAbs Therapeutics downgraded to Hold from Buy at Canaccord
1M ago
YMAB
Premium
The Fly
Y-mAbs Therapeutics upgraded to Equal Weight from Underweight at Morgan Stanley
1M ago
YMAB
Premium
Ratings
Hold Rating Issued Amidst SERB Pharmaceuticals’ Acquisition of Y-mAbs Therapeutics
1M ago
YMAB
Premium
The Fly
Y-mAbs Therapeutics downgraded to Hold from Buy at Truist
1M ago
YMAB
Premium
The Fly
Y-mAbs Therapeutics downgraded to Hold from Buy at Brookline
1M ago
YMAB
Premium
The Fly
Y-mAbs Therapeutics downgraded to Neutral from Overweight at Cantor Fitzgerald
1M ago
YMAB
Premium
The Fly
Y-mAbs Therapeutics downgraded to Hold from Buy at Clear Street
1M ago
YMAB
Premium
The Fly
Y-mAbs Therapeutics downgraded to Hold from Buy at JonesResearch
1M ago
YMAB
Premium
The Fly
Palantir reports Q2 beat, Caterpillar posts mixed results: Morning Buzz
1M ago
W
IT
Premium
The Fly
Y-mAbs Therapeutics downgraded to Neutral from Outperform at Wedbush
1M ago
YMAB
Premium
Company Announcements
Y-Mabs Therapeutics Announces Merger with SERB Pharmaceuticals
1M ago
8K
YMAB
Premium
The Fly
Y mAbs Therapeutics trading resumes
1M ago
YMAB
Premium
The Fly
SERB to acquire Y-mAbs Therapeutics for $8.60 per share in cash
1M ago
YMAB
Premium
The Fly
Y mAbs Therapeutics trading halted, news pending
1M ago
YMAB
Premium
Company Announcements
Y-Mabs Therapeutics Elects New Director at Annual Meeting
2M ago
8K
YMAB
Premium
Ratings
Promising R&D Developments and New Radiohapten Propel Y-Mabs Therapeutics to a Buy Rating
3M ago
YMAB
Premium
Ratings
Optimistic Outlook on Y-mAbs Therapeutics’ GD2-SADA Platform Despite Developmental Delays
3M ago
YMAB
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
